Verified laboratory assays, rigorous HPLC testing, and global export packaging for seamless cross-border logistics.
Understanding the specialized biochemical role of Bifidobacterium longum subsp. infantis across metabolic health, infant formula innovation, and therapeutic gut ecology.
Unlike other probiotic strains, B. infantis possesses an intracellular gene cassette spanning over 40 kb that encodes dedicated ABC transporters and glycosyl hydrolases. This allows full internalization and consumption of Human Milk Oligosaccharides (HMOs) like 2'-fucosyllactose (2'-FL), releasing life-critical Short-Chain Fatty Acids (SCFAs) without generating gas.
Bulk formulations containing viable B. infantis stimulate the expression of occludin and zonula occludens-1 (ZO-1) proteins. This clinical dynamic mitigates intestinal permeability ("leaky gut"), limits circulating lipopolysaccharides (LPS), and downregulates pro-inflammatory cytokines including TNF-α and IL-6 within the intestinal lamina propria.
Advanced metabolic profiling indicates high-viability strains convert dietary tryptophan into indole-3-lactic acid (ILA). ILA serves as a natural ligand for the aryl hydrocarbon receptor (AhR), which primes anti-inflammatory immune signaling, enhances naive T-cell balance toward protective Treg populations, and establishes lifelong autoimmune tolerance.
| Quality Metric / Parameter | Standard Commodity Grade | Our Export-Grade China Facility Standard | Analytical Standard |
|---|---|---|---|
| Viable Cell Count (CFU/g) | 10 Billion – 50 Billion CFU/g | 100 Billion – 500 Billion CFU/g (Ultra-Dense) | Plate Count / Flow Cytometry (ISO 19344) |
| Water Activity (aW) | ≤ 0.15 aW | ≤ 0.05 aW (Nitrogen Protected) | Chilled Mirror Dew Point |
| Gastric Acid Survival Rate (pH 2.0, 2h) | < 35% Viability | ≥ 92.4% (Multi-layer Microencapsulated) | In Vitro Simulated Gastric Fluid (USP) |
| Thermal Tolerance (40°C, 75% RH, 30d) | Log reduction > 2.5 | Log reduction < 0.35 (Stabilized Carrier Matrix) | ICH Accelerated Stability Guidelines |
Shaanxi ShineHerb Biotech leverages high-density submerged fermentation technology in Xi'an's national high-tech corridor, reducing unit cost while exceeding Western pharmacopoeial standards.
Using digital mass flow controllers and real-time gas analytics, our 20-ton fermenters maintain steady-state pH, dissolved oxygen, and nutrient feed, preventing strain degeneration and maximizing cell-wall integrity.
Our patented pre-freezing cooling curve coupled with an organic-derived polysaccharide cryoprotectant matrix protects cell membrane structures from ice crystal shearing during sublimation drying.
Milling, blending, and barrier packaging occur in strictly controlled environments under -40°C dew-point conditions with nitrogen purge to ensure zero premature bacterial metabolic wake-up.
By producing complementary vitamins, amino acid chelates, and natural enzymes under one roof, buyers aggregate multi-ingredient shipments into single customs entries, sharply lowering landed costs.
Our stabilized Bifidobacterium infantis bulk powder meets regulatory monographs across North America, the European Union, Southeast Asia, and the Middle East.
Engineered to dissolve uniformly in infant formulas, probiotic oil drops, and weaning food supplements without alterating dairy sensory profiles. Completely compliant with zero-pathogen, ultra-low heavy metal tolerances (Pb < 0.05 mg/kg, As < 0.05 mg/kg).
Optimized for hard-gelatin, HPMC, and delayed-release acid-resistant enteric capsules. Clinical evidence links B. infantis to significant reductions in abdominal bloating, visceral hypersensitivity, and bowel irregularity in adult populations.
Specialized low-moisture formulations specifically prepared for chewable gummies, sachet drink sticks, and fast-dissolving tablets. Retains viable activity alongside active enzymes, plant polyphenols, and micronutrient premixes.
Contract manufacturing trends highlight rapid pivot points for sourcing directors and formulation teams in the probiotics industry.
Global brands are pivoting away from generic probiotic mixtures toward single-strain accountability. Buyers demand genomic sequence matching (16S rRNA / Whole Genome Sequencing) verifying that the exported strain corresponds with established human safety records.
Historically dominated by high-markup European producers, bulk buyers are diversifying supply chains. Direct access to certified Chinese manufacturers delivers identical genetic profiles and higher live CFU overages at 30% to 50% lower input costs.
Increasing incidence of infant and pediatric allergies mandates zero-dairy, non-GMO, and allergen-free fermentation media. Our production line uses hydrolyzed vegetable peptone broth, fully eliminating cow's milk protein and soy allergens.
Every commercial consignment of Bifidobacterium infantis ships with comprehensive testing protocols ensuring seamless custom clearances and local authority approvals.
Released strictly against verified USP and European Pharmacopoeia microbiological assays, including validated aerobic mesophilic plate count, mold/yeast counts, and absence of pathogens (Salmonella, E. coli, Staphylococcus aureus).
Strict quantitative evaluation of toxic heavy metals via Inductively Coupled Plasma Mass Spectrometry: Lead < 0.1 ppm, Arsenic < 0.1 ppm, Cadmium < 0.05 ppm, Mercury < 0.01 ppm.
Fully certified under ISO 9001:2015, ISO 22000, HACCP Food Safety Management, cGMP compliance, Halal (MUI standard), and Kosher certification for broad multinational market acceptability.
Vacuum-sealed double aluminum-foil pouching inside heavy-duty fiber drums. Shipped via temperature-controlled air freight or reefer sea containers with continuous digital temperature loggers.
Practical technical and commercial answers tailored for R&D chemists, QA controllers, and international purchasing executives.
Our raw active powder is genetically designated as Bifidobacterium longum subsp. infantis. We supply standard standardized bulk concentrations of 50 Billion CFU/g, 100 Billion CFU/g, and ultra-concentrated unblended freeze-dried pure culture exceeding 500 Billion CFU/g. Custom dilutions blended with certified carriers (maltodextrin, resistant dextrin, or inulin) are formulated upon request.
All bulk probiotic strains undergo specialized microencapsulation with trehalose and protective oligosaccharides, achieving extreme resistance against osmotic shock and temperature spikes. Finished goods are sealed in multi-layer moisture-proof, oxygen-barrier aluminum-foil bags within a Class C cleanroom under nitrogen purge. Shipments depart via express temperature-regulated cold-chain transport with real-time temperature loggers.
Each consignment is accompanied by a batch-specific Certificate of Analysis (COA) detailing total viable count, heavy metal breakdown via ICP-MS, moisture content, water activity (aW), and complete microbiological purity tests. On request, we provide Material Safety Data Sheets (MSDS), Technical Data Sheets (TDS), Flowcharts, Allergen Statements, Non-GMO Attestations, and valid copies of ISO, GMP, Kosher, and Halal certificates.
Yes. Our Xi'an processing facility features high-efficiency 3D industrial blenders capable of producing custom multi-strain complexes (such as combinations of B. infantis, L. rhamnosus, B. lactis, and HMOs). We conduct comprehensive carrier compatibility and moisture equilibrium audits to verify that the active CFU remains stable throughout your target shelf-life.
Our standard Minimum Order Quantity (MOQ) is 1 kg for catalog test batches and initial validation trials. For commercial orders (25 kg to metric ton orders), lead time is typically 5 to 10 working days from formulation confirmation to export dispatch out of Shanghai or Beijing airports.
Explore additional verified dietary supplement raw materials, enzymes, and specialized cosmetic intermediates.